Re new stock (see prior post), I want to know what's going on. Maybe it was in the Q3 report and I missed it? It makes no sense to issue new stock to raise more capital privately, if they are sincere about doing an IPO next year, as explicitly advertised. They have enough cash for operations, as far as I know, and revenues are beginning to ramp up -- if nothing else, the $2 million from European Wellness will begin to kick in soon. If it's not for a fantasy IPO, are they issuing new shares just to distribute to insiders (current or new)? Geez, I hope not -- that would be a signal for legacy shareholders to act. I guess we'll see soon enough. OTOH, if it's for an IPO, then it's a smallish IPO (7 million shares), which would be fine by me. My gut is saying that $35-50 million dollars is probably about right for their current status and near-term growth needs, if they can sell the shares.